Thursday 3 October 2019
Investorideas.com - Cannabis Research News: U.S. Federal Cannabis Legalization Could Be Worth $128.8 Billion in Taxes and 1.6 Million Jobs
Investorideas.com - Cannabis Research News: U.S. Federal Cannabis Legalization Could Be Worth $128.8 Billion in Taxes and 1.6 Million Jobs
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $WEED.TO) (NYSE: $CGC) (TSX: $RIV.TO) (OTC: $CNPOF) (CSE: $FONE.C) (OTCQX: $FLOOF), (CSE: $PLTH.C) (OTCQX: $PLNHF)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move:
(TSX: $WEED.TO)
(NYSE: $CGC) (TSX: $RIV.TO) (OTC: $CNPOF) (CSE: $FONE.C) (OTCQX: $FLOOF),
(CSE: $PLTH.C)
(OTCQX: $PLNHF)
Delta, Kelowna, BC –October 3, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/10031WEED-CGC-RIV-CNPOF-FONE-FLOOF-PLTH-PLNHF.asp
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In
today’s podcast we look at announcements from today and earlier this week.
But
first, Province Brands of Canada's
co-located subsidiary, Evolved Canna-Innovation Labs, announced that it has received its research and
development license from Health Canada. The license permits an in-house
pharmacology and pharmacokinetics laboratory and cannabis research facility in
Province Brands' 123,000 square-foot facility in Grimsby, Ontario. Province
Brands' subsidiary will use the license to continue its ongoing R&D into
creating valuable intellectual property, enabling the worlds' first fermented
beverages brewed from the cannabis plant. This moves Province Brands one step
closer toward a 2020 Canadian retail product launch for their versatile
portfolio of premium and super premium adult cannabis beverages.
Province Brands is the only known company
exclusively focused on brewed or fermented beverages to receive Health Canada's
cannabis research greenlight. The
Company has invested more than $CAN10 million in direct R&D costs and has
assembled a team of globally renowned bioprocess chemists, bioprocess
engineers, pharmacologists and cannabinoid researchers to develop premium
cannabis beverages crafted in an entirely new brewing tradition. The
patent-pending technology enabling this new tradition helps Province Brands
avoid many of the problems and pitfalls commonly found in cannabis-infused
beverages and helps bring the company closer to its goal of creating a less
harmful alternative that can be used in all the same social and leisure
settings as alcohol.
For the past three years, Province Brands'
industry-leading R&D team has been conducting research at colleges,
universities, Contract Research Organizations, and other appropriately-licensed
venues. The company's researchers will
now be able to work directly with cannabis in the 123,000 square-foot facility
in Grimsby, Ontario.
With the newly granted research license,
Province Brands will focus on increasing the carryover of cannabinoids from the
plant matter into the Company's final products and continue development of
technologies aimed at creating a beverage with a dose/response curve similar to
that of alcohol. Additionally, the
company will develop protocols for cell-based research to advance its
understanding of the phytocannabinoid pharmacology for future product
developments.
StrainprintR Technologies
Ltd. expanded their international reach with the addition
of Tikun Olam, an award-winning medical cannabis cultivation and research
company to their growing portfolio of cannabis-based businesses.
The
world's first licensed cannabis company, Tikun Olam is the recognized global
leader in cannabis research and developed the world's first-ever, high-CBD,
low-THC, cannabis varietal Avidekel™ to treat adult and child patients alike
with broad-spectrum cannabinoids without a psychoactive effect. Since 2002, the
company has been on a mission to "Repair the World" with plant-based
medicine. With operations in Israel, Canada, Australia, the UK, and the US,
Tikun Olam is both a cultivator of multiple award-winning strains, as well as a
premier producer of broad-spectrum CBD products.
"Tikun's
unique proprietary strains have been developed specifically for symptomatic
relief and efficacy and are backed by over a decade of research," said
Stephen Gardner, Chief Marketing Officer of Tikun Olam. "Our commitment to
producing the world's most effective therapeutic strains led us to Strainprint
because of their unwavering endorsement of the scientific understanding of
cannabis and its legitimacy as a therapy."
Tikun
Olam will leverage the
Strainprint Analytics web platform, the most sophisticated
cannabis analytics source available to help identify patterns for the products
they cultivate, process or distribute. The company will be able to broaden
their already robust patient data and provide the best recommendations for
medical cannabis prescription and delivery method to patients of all ages. The
platform is built on top of the largest and most granular scientific data set
of its kind in the world, with more than 1.4 million anonymized, patient
reported medical cannabis outcomes and more than 70 million data points on
strain efficacy.
Their
medical cannabis patients will also have access to Tikun Olam's custom-branded
version of the
Strainprint mobile app. The app is free, allowing them to track
their treatment sessions in real-time and understand how to achieve the best
results for their symptoms. The custom-branded version of the app includes
loyalty tools that drive engagement through redeemable discounts on merchandise.
"We
are naturally drawn to partners who share our drive to further understand the
benefits of medical cannabis and continue to change society's perception,
reducing social stigmas," said Strainprint CEO, Andrew Muroff. "We
are so pleased that such a reputable global brand chose to work with us,
trusting that we have the best tools and data available today. Tikun Olam is
producing some of the highest medical value strains on the market, and we are
thrilled to open up our technology platform to help take their research and
development to the next level."
Tikun
Olam will also have access to a "sandbox" testing environment of
their own patient data. Here they will be able to test a variety of hypotheses
about the data and analytics.
Canopy
Growth Corporation (TSX: WEED) (NYSE: CGC) announced that it has completed an all-cash
transaction to purchase a majority stake in BioSteel Sports Nutrition Inc., a
leading producer of sports nutrition products. The transaction provides Canopy
Growth with a significant platform to enter the sports nutrition and hydration
segment, and lays the groundwork for the adoption of CBD in future product
offerings in accordance with regulations globally including products to be sold
in the U.S. containing CBD sourced from federally permissible industrial hemp.
Founded in 2009, BioSteel's focus on
premium natural ingredients, product transparency, and identifying the
essential nutrients needed to power physical activity has led to the brand
achieving a reputation for being the hydration product provider of choice for
high performance athletes. BioSteel products have been purchased by over 70% of
the teams in North America's four major sports leagues and ambassadors of the
brand include: Ezekiel Elliott, of the Dallas Cowboys; Connor McDavid, of the
Edmonton Oilers; WTA player, Eugenie Bouchard; Andrew Wiggins with the
Minnesota Timberwolves; Tyler Seguin with the Dallas Stars; Jalen Ramsey, with
the Jacksonville Jaguars; NHL Hall of Famer, Wayne Gretzky; Gleyber Torres,
with the New York Yankees; and Smiths Falls very own, LPGA golfer Brooke
Henderson. In particular, Elliott's agreement with BioSteel allows them to
activate the star running back as the leading endorser of CBD products once
permitted by the NFL. To date no active player has been able to do so.
In addition, BioSteel has national
organizational partnerships with USA Hockey, Canada Basketball, Athletics
Canada and the Professional Hockey Players Association. The company has 10,000+
points of distribution in Canada and the U.S. and continues to expand in both
markets and into Europe.
"BioSteel has a reputation for being a
best-in-class provider of natural sports nutrition products and all of its
products are well positioned to benefit from the increasing trend of
plant-based and all-natural products, preferred not only by professional
athletes, but active consumers as well," commented Mark Zekulin, CEO,
Canopy Growth. "This acquisition allows us to enter the sports nutrition
space with a strong and growing brand as we continue towards a regulated market
of food and beverage products that contain cannabis. We view the adoption of
CBD in future BioSteel offerings as a potentially significant and disruptive
growth driver for our business."
"The use and acceptance of CBD-based
products in the professional sports landscape has changed. We have witnessed
the negative effects of prescription painkillers and athletes are looking for
healthier alternatives," said Michael Cammalleri, Co-Founder and Co-CEO,
BioSteel Sports Nutrition. "Its presence is already commonplace amongst
NHL players and as a regular CBD user myself, I couldn't be more proud to
champion BioSteel's evolution and leadership in this space."
"Since inception, BioSteel has taken
great pride in being at the forefront of healthy and natural sports nutrition.
Joining Canopy Growth, the world leader in cannabis research, development and
production, reflects the natural evolution of our brand and will allow us to
expand our product offering and global distribution," said John Celenza,
Co-Founder and Co-CEO, BioSteel Sports Nutrition. "The consumer market and
many of our athletes have a growing knowledge of cannabis and CBD products and
this partnership ensures that we will continue to raise the bar in the sports
nutrition field."
Today's announcement further advances
Canopy Growth's ongoing multi-faceted strategy to enter new markets with a
platform spanning production, distribution and marketing of CBD products
derived from hemp and cannabis in accordance with regulations across a number
of different verticals. The transaction gives Canopy Growth a 72% stake in
BioSteel with an agreed upon path to 100% ownership.
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) has completed a US $10 million investment in TerrAscend Canada Inc., a subsidiary of
its portfolio company TerrAscend Corp.
(CSE: TER) (OTCQX: TRSSF).
TerrAscend
is the first and only cannabis company with sales in Canada, the U.S., and
Europe. TerrAscend's international cannabis portfolio includes a robust research
and development platform, domestic and international cultivation, processing,
and distribution facilities, and a portfolio of medical and adult-use branded
cannabis products, and is one of a select group of industry operators to have
been recognized with a European Good Manufacturing Practices certification.
TerrAscend is also an active participant in the Canopy Rivers ecosystem, with
significant agreements in place with Canopy Rivers portfolio companies
PharmHouse Inc. and James E. Wagner Cultivation Corporation.
"We
think TerrAscend is uniquely positioned to meet the evolving consumer demands
in the three largest cannabis markets worldwide," said Narbe Alexandrian,
President & CEO of Canopy Rivers. "We strongly believe in TerrAscend's
ability to execute on its global strategy, market a diversified brand
portfolio, and build on its recent acquisitions, and this additional investment
is an affirmation of that belief."
Flower One Holdings
Inc. (CSE: FONE) (OTCQX: FLOOF), announced that it has initiated its West Coast
expansion. After successfully delivering the largest facility in Nevada, from
conception to revenue generation in less than 14 months, Flower One has now set
its sights on California as its next strategic market.
At
455,000 square feet, Flower One's existing Nevada facility is the largest
cannabis greenhouse and production facility in the state. Plans for California
entry will see the Company leverage the many cannabis-specific operational
proficiencies and manufacturing methodologies it has developed in Nevada, to
make it an industry leader and innovator in the state of California.
"Flower
One's expansion to California is a natural and logical progression," said
Ken Villazor, President and CEO of Flower One. "With California's
proximity to Nevada, we are able to leverage processes and efficiencies already
established as they relate to cannabis production and cultivation, as well as
management, purchasing, training, and brand engagement. Our experienced team
and the expertise gained from our successful Nevada market entry and roll out,
provides us with an excellent foundation to seed our California
operations."
Building
off of its success in Nevada, where it achieved record cannabis yields and
boasts the lowest reported production cash cost per gram in the industry at
US$0.45 (US$205 per pound), Flower One's strategic efforts for market entry
into California have been underway for the better part of a year. Leveraging
the skills of a highly specialized and experienced team, the Company has
conducted thorough analyses of various locations for climate, water, power, tax
structures, and labor quality and supply. Strong engagement with local
government entities including City, County and State has allowed the site
selection process to narrow and negotiations to begin for purchase of a
property.
"What
Flower One has accomplished in Nevada is nothing short of spectacular,"
said Kellen O'Keefe, Chief Strategy Officer at Flower One. "We are
confident in our team's capabilities – armed with over 25 years of experience
in building and operating some of the largest greenhouse facilities in the
world. We can't wait to bring Flower One to the largest legal cannabis market
in the U.S."
According
to leading market research firm Arcview, California will grow from its current
market of $3.1 billion in sales to over $7.2 billion by 2024. Flower One is
positioning itself to become one of the largest and most important seed to
shelf cannabis brand fulfillment companies on the West Coast.
Planet 13 Holdings
Inc. (CSE: PLTH) (OTCQX: PLNHF) announced that has it served an average of 1,970
customers per day in September at an average ticket of $94.73 from the Planet
13 Las Vegas Cannabis Entertainment Complex.
“We
have been experimenting with different combinations of pricing, product deals,
and advertising to determine the optimal mix to maximize gross profit. You can
see this effect in September resulting in a significant pickup in average
ticket and our second highest average daily revenue month. This large per day
revenue number was achieved despite West Desert Inn Road, where Planet 13 is
located, being under construction for most of the month. The county has added
new pedestrian lights and crosswalk in front of the store to help pedestrians
cross the street safely at all times," said Bob Groesbeck, Co-CEO of
Planet 13. "Starting in October we will be driving additional traffic from
our restaurant, café, event center and customer-facing production facility.
Over the course of Q4 and Q1 2020 our internal goal is to grow sales of
non-flower in-house brands to drive additional margin and create lasting brand
recognition."
Construction
on Phase II expansion, which includes a restaurant, café, event center, and
customer-facing production facility, is largely complete as of October 1st,
2019. The restaurant is expected to open on or around October 11th,
2019 pending final inspection and approval from County and Health inspectors.
The
15,000 sq. ft. customer-facing production facility is expected to begin
operations on or around October 15th, 2019 pending final approval of
transfer of production license from Planet 13's existing 2,000 sq. ft.
production facility.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Wednesday 2 October 2019
Investorideas.com - Cannabis Stock News: Westleaf (TSX-V: WL) (OTCQB: WSLFF) Receives Additional $5.7 Million of Capital from ATB Financial
Investorideas.com - Cannabis Stock News: Westleaf (TSX-V: WL) (OTCQB: WSLFF) Receives Additional $5.7 Million of Capital from ATB Financial
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Nation's Largest Marijuana Policy Reform Group Releases Report on Cannabis Vaping Regulations
Investorideas.com - Nation's Largest Marijuana Policy Reform Group Releases Report on Cannabis Vaping Regulations
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...